Home » Purchase of Allos Therapeutics Is Completed

Purchase of Allos Therapeutics Is Completed

September 6, 2012

Spectrum Pharmaceuticals has completed its acquisition of Colorado biotech Allos Therapeutics.
Denver Business Journal

19Jan
Pharmaceutical Quality Risk Management: Navigating the Intersection Between Regulatory Requirements & Risk Management
21Jan
Virtual MDSAP Audits in the Era of COVID-19: What to Know and Do to Pass Virtual Audits
26Jan
Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup
27Jan
Medical Device Clinical Trials in China: Latest Regulatory Developments
27Jan
FDA’s Response to COVID-19: Fundamentals of Obtaining Emergency Use Authorizations
09Feb
Maintaining Your Risk-Based Cleaning and Disinfectant Programs: Best Practices During COVID-19

Featured Products

Featured Stories

The Revised ICH E8: A Guide to New Clinical Trial Requirements